Search results
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Zacks· 6 days agoMaking its debut on 06/23/2005, smart beta exchange traded fund Invesco Biotechnology & Genome ETF (PBE Quick QuotePBE - Free Report) provides investors broad exposure to the Health Care ETFs ...
FDA considers Dupixent for adolescent sinusitis treatment By Investing.com
Investing.com· 3 days ago(NASDAQ: REGN) and Sanofi (NASDAQ:SNY). This review is for Dupixent as an add-on maintenance...
Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
Zacks via Yahoo Finance· 2 days agoBayer's (BAYRY) Q1 earnings and sales decline year over year due to a fall in volumes for...
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Zacks via Yahoo Finance· 3 days agoLooking at individual holdings, Neurocrine Biosciences Inc (NBIX) accounts for about 5.26% of total...
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Zacks via Yahoo Finance· 6 days agoWhen you look at individual holdings, Neurocrine Biosciences Inc (NBIX) accounts for about 5.26% of...
Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates
Zacks· 6 days agoIntellia's (NTLA) earnings and revenues surpass estimates in the first quarter of 2024. The company provides developmental and regulatory updates on its pipeline candidates. Stock rises.
Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
Zacks· 2 days agoBayer's (BAYRY) Q1 earnings and sales decline year over year due to a fall in volumes for non-glyphosate-based herbicides and lower prices for glyphosate-based products in the Crop Science division.
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 3 days agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Zacks· 3 days agoBiotech segment of the equity market, the Invesco Biotechnology & Genome ETF (PBE Quick QuotePBE - Free Report) is a passively managed exchange traded fund launched on 06/23/2005. Retail and ...
Regeneron shares rise on Evercore ISI Outperform rating By Investing.com
Investing.com· 3 days agoOn Monday, Evercore ISI initiated coverage on Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:...